$1.75
0[0.00%]
At close: Apr 18
$1.75
0[0.00%]
After Hours: 7:22PM EDT
Cardiol Therapeutics
(NASDAQ:CRDL)Cardiol Therapeutics Stock (NASDAQ:CRDL), Earnings Estimates, EPS, and Revenue
Cardiol Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-0.100
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Cardiol Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | PM | CRDL | Q1 | -$0.08 | -$0.10 | — | — | $0.00 | — | — | — | Get Alert |
| 04/01/2024 | PM | CRDL | Q4 | -$0.08 | -$0.12 | -$0.09 | 25.00% | $0.00 | — | $0.00 | — | Get Alert |
| 11/14/2023 | PM | CRDL | Q3 | -$0.10 | -$0.09 | -$0.07 | 22.22% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2023 | PM | CRDL | Q2 | -$0.08 | — | -$0.09 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/15/2023 | PM | CRDL | Q1 | -$0.11 | — | -$0.08 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/29/2023 | PM | CRDL | Q4 | -$0.11 | -$0.11 | -$0.08 | 27.27% | $0.00 | — | $0.00 | — | Get Alert |
| 11/10/2022 | PM | CRDL | Q3 | -$0.23 | — | -$0.10 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2022 | PM | CRDL | Q2 | -$0.13 | — | -$0.08 | — | $64.10K | — | $0.00 | — | Get Alert |
| 05/16/2022 | PM | CRDL | Q1 | -$0.21 | — | -$0.11 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/23/2022 | PM | CRDL | Q4 | — | — | -$0.11 | — | — | — | $0.00 | — | Get Alert |
| 11/15/2021 | PM | CRDL | Q3 | -$0.10 | — | -$0.18 | — | $0.00 | — | $0.00 | — | Get Alert |
FAQ
When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?
Cardiol Therapeutics (CRDL) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on April 1, 2024 for Q4.
What were the latest earnings per share (EPS) for Cardiol Therapeutics (NASDAQ:CRDL)?
The Actual EPS was $-0.09, which beat the estimate of $-0.12.
What were Cardiol Therapeutics’s (NASDAQ:CRDL) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.